An interventional study of Case Management in Chronic Obstructive Pulmonary Disease (COPD), sponsored by Kronikerenheden Nordjylland. Completed at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2015-04-01.
Sponsored by Kronikerenheden Nordjylland · Not applicable, Interventional, and Health services research
This randomized controlled trial (RCT) will examine a nurse case management model for patients suffering from chronic obstructive pulmonary disease (COPD) in a Danish municipality, and is performed in order to evaluate the use of case management as a tool in achieving integrated, quality and cost-effective care for this group of patients.
The main objectives are to evaluate how case management influences on hospital admissions, mortality, quality of life and self care, as well as to compare costs and cost-effectiveness of case management vs. usual care.
Case management is being implemented as a health service strategy that should contribute to maximize health outcomes within a cost-constrained environment. Evaluations of case management in Danish settings are sparse, and so far no Danish studies have evaluated the cost-effectiveness of case management.
This study is performed as a RCT, and the study focuses exclusively on patients with COPD. The patients will be enrolled and randomized after being referred to rehabilitation at the local rehabilitation center in Aalborg municipality, Denmark. 150 patients will be randomly assigned to two groups of 75 patients each. Participants in the control group will receive usual care, whereas patients assigned to the interventional group will receive case management besides their usual care. Each patient will be followed for 12 months. Patients in both groups will fill out questionnaires at baseline and 12 months. The data register system "Health - Planning and Quality" in the Northern Region of Jutland will be used to determine health care services and costs.
3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.
This study's enrollment of 150 is above the median of 72 across 2,118 interventional studies indexed under Lung Diseases.
Browse Lung Diseases studies →This is the only study on the registry with Kronikerenheden Nordjylland as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The patients who are randomized to the intervention group will be assigned to case management. The case manager is expected to integrate care from a health maintenance and promotion perspective, where the overall goal is the promote and support the patients self care (see intervention description).
Behavioral: Case Management
Patients randomized to the usual care group will receive conventional health and social services. Patients in this group will not receive support from a case manager.
Patients, who are randomized to the intervention group, will receive case management from a trained and experienced nurse. The case manager will carry out following tasks: * Formulation and implementation of care plans together with the patient * Monitoring of individual status and care plan effectuation * Overall coordination between health care providers * Support to the patient and their caregivers during times of transition related to health status and environmental changes (e.g. hospital to home) * Regular telephone consultations and home visits * Promote disease-self management through coaching
Also known as: Care management, integrated care, shared care
COPD hospitalization rates
Time frame: 1 year (study inclusion - 12 months of follow-up)
Mortality
Time frame: 1 year (study inclusion - 12 months of follow-up)
Self Care
The Patient-Activation Measure short form (PAM-13) will be used to evaluate change in self care. The investigators will obtain 2 measurements from each patient during the study period.
Time frame: A baseline measure at study inclusion and after 12 months of follow-up
Quality of Life (QoL)
The investigators will obtain 2 measurements from each patient and are therefore able to evaluate the change in Qol from baseline to end of study (1 year in total). Both generic (EQ-5D, SF-12) and disease-specific questionnaires (Sct. George Respiratory questionnaire, SG-RQ) will be used.
Time frame: A baseline measure at study inclusion and after 12 months of follow-up
Cost-effectiveness of case management
The cost-effectiveness analysis will examine and compare the cost of health care resources and health outcomes between the two groups. The costs will include all health care utilization during the 1 year of follow-up. Quality adjusted life years (QALYs) is the preferred measure for cost-effectivenes analysis. QALYs will be calculated based on the EuroQol (EQ-5D).
Time frame: 1 year
This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.